Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Maria-Genalin Angelo"'
Autor:
Frank Huygen, Kristin Verschueren, Candida McCabe, Jens-Ulrich Stegmann, Julia Zima, Olivia Mahaux, Lionel Van Holle, Maria-Genalin Angelo
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1114-1121 (2015)
Complex regional pain syndrome (CRPS) is a chronic pain disorder that typically follows trauma or surgery. Suspected CRPS reported after vaccination with human papillomavirus (HPV) vaccines led to temporary suspension of proactive recommendation of H
Externí odkaz:
https://doaj.org/article/5fbfeda6fcbe4c86a82a399e4bcd4760
Autor:
Laurence Baril, Tjeerd van Staa, Sonia Hernandez-Diaz, Rachael Boggon, Dominique Rosillon, Maria Genalin Angelo, Eveline M Bunge, Judith H van den Bosch, Corinne Willame, Christina D. Chambers, Julia Zima
Publikováno v:
Vaccine. 33(48):6884-6891
Background We assessed the risk of spontaneous abortion (SA) after inadvertent exposure to HPV-16/18-vaccine during pregnancy using an observational cohort design. Methods The study population included women aged 15–25 years registered with the Cli
Autor:
Lionel Van Holle, Maria-Genalin Angelo, Jens Ulrich Stegmann, Olivia Mahaux, Julia Zima, Candida S. McCabe, Frank J P M Huygen, Kristin Verschueren
Publikováno v:
EBioMedicine, Vol 2, Iss 9, Pp 1114-1121 (2015)
EBioMedicine, 2(9), 1114-1121. Elsevier
EBioMedicine, 2(9), 1114-1121. Elsevier
Complex regional pain syndrome (CRPS) is a chronic pain disorder that typically follows trauma or surgery. Suspected CRPS reported after vaccination with human papillomavirus (HPV) vaccines led to temporary suspension of proactive recommendation of H
Autor:
Sylvia Taylor, Laurence Baril, Dominique Rosillon, Gary Dubin, Maria-Genalin Angelo, Frank Struyf, Fernanda Tavares Da Silva, Felix Arellano, Marie-Pierre David
Publikováno v:
Expert Review of Vaccines. 13:1297-1306
The HPV types 16/18-AS04-adjuvanted cervical cancer vaccine, Cervarix(®) (HPV-16/18-vaccine, GlaxoSmithKline, Belgium) was first approved in 2007 and is licensed in 134 countries for the prevention of persistent infection, premalignant cervical lesi
Autor:
Felix Arellano, Laurence Baril, Marie-Pierre David, Gary Dubin, Julia Zima, Maria-Genalin Angelo, Frank Struyf
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose The purpose of this study is to further evaluate the safety of the human papillomavirus (HPV)-16/18-AS04-adjuvanted vaccine (HPV-16/18-vaccine Cervarix®, GlaxoSmithKline, Belgium) through a pooled analysis of data from 42 completed/ongoing c
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose To summarise post-licensure safety surveillance over more than 4 years of routine use of the human papillomavirus-16/18-AS04-adjuvanted vaccine (HPV-16/18 vaccine: Cervarix®, GlaxoSmithKline, Belgium). Methods We describe global post-licensu
Autor:
Tiina Eriksson, Dan Bi, Eero Pukkala, Frank Struyf, Kari Natunen, Julia Zima, Mari Hokkanen, Jorma Paavonen, Marie-Pierre David, Matti Lehtinen, Dan Apter, Maria-Genalin Angelo, Gary Dubin, Sanjoy K Datta
Publikováno v:
Human Vaccines & Immunotherapeutics
This community-randomized controlled trial was initiated to assess the overall and herd effects of 2 different human papillomavirus (HPV) immunization strategies in over 80,000 girls and boys aged 1215 y in 33 communities in Finland (ClinicalTrials.g